HTB

2001

John Le Carre describes drug industry’s ‘crimes of unbridled capitalism’ in Nation column

College students protest university patents on AIDS drugs

AIDS care for Africa affordable

Tony Blair sides with drug giants

IAPAC to launch HIV training, certification program for developing world physicians

Outcome of patients with discordant responses to HAART

Self-reported symptoms after starting HAART help predict adherence

DuPont applies to FDA for approval of one-tablet, once daily formulation of efavirenz

Patient age influences CD4+ cell recovery with HAART

2nd International workshop on Clinical Pharmacology of HIV Therapy, 2-4 April, Noordwijk, The Netherlands

First randomised trial shows clinical benefit of TDM for people using nelfinavir or indinavir containing combinations

Preliminary data from four studies of double PI regimen using once daily Fortovase plus “mini dose” ritonavir

Clinical Pharmacology of Antiretroviral Therapy, Liverpool, UK , March 2001

HIV/HCV coinfection: amid swirling controversy the profile of a killer emerges

French study finds low death rate due to hepatitis C virus in HIV-positive patients

Cancer risk increased with AIDS

HAART lowers CIN recurrence risk in HIV-positive women

HIV status predicts anal dysphasia and carcinoma risk in HPV-infected individuals

Anal neoplasia grade linked with genetic changes

Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection

Antiretroviral therapy improves measles vaccination response in HIV-infected children

Drug resistant HIV spreading in UK

South African panel recognizes HIV as cause of AIDS

Volume 2 Number 4 May 2001 PDF

8th Conference on Retroviruses and Opportunistic Infections

Paediatric treatment issues at the 8th CROI

South African court battle damages drug industry’s image

Red Cross slams drug firms over pricing policies

Medecins Sans Frontieres urges drugs giants to drop South Africa suit

Second Indian firm offers cut-price HIV drugs

Yale pressed to help cut drug costs in Africa

GlaxoSmithKline offers 90% discount on HIV drugs to Africa

HIV drug prices cut for poorer countries

Bristol-Myers Squibb offers to sell AIDS drugs in Africa at below cost

Roche and Trimeris announce US sites and investigators for T-20 phase III study; activists want wider access to drug for sickest AIDS patients

European activists demand greater access to T-20

European marketing approval granted for lopinavir/r (Kaletra)

Despite differences in viral load, men and women develop AIDS at the same rate

Thymic output of CD4+ cells contributes to CD4+ cell and viral load dissociation

HIV evolves independently in blood and CSF

CTLs decrease with combination antiretroviral therapy but precursor cells remain

HIV-1 strains using the CXCR4 co-receptor are suppressed with potent therapy

Interleukin-2 improves CD4+ cell counts in patients with poor immune response to HAART

Roche’s valganciclovir for AIDS-related eye infections backed by FDA panel

Topical docosanol may be beneficial in treating HIV-related Kaposi’s sarcoma

AIDS-related abdominal disease does not increase surgery risk in AIDS patients

Risk of lipodystrophy in HIV-positive treated with PIs: a prospective cohort study

Protease inhibitor use not linked to atherosclerosis in middle-aged HIV patients

Efavirenz use in HIV-positive children

Steatorrhea prevalent in HIV-positive children; clinical significance unclear

Pain common among HIV-positive individuals

Manifestations of syphilis similar in HIV positive and HIV negative subjects

HAART improves subcortical functioning in cognitively impaired HIV patients

Link documented between problem drinking, noncompliance with HIV treatment

Stress, anger bad for HIV patients’ immune system

Grief counselling may lower HIV viral load

Use of cytokines in HIV: colony-stimulating factors, erythropoietin, and interleukin-2

Volume 2 Number 3 April 2001 PDF

8th Conference on Retroviruses and Opportunistic Infections, February 4-8 2001, Chicago, USA

From talk to action in fighting AIDS in the developing countries: 8th Retrovirus Conference opening session

UNAIDS calls for new deal between pharmaceutical companies and society

US trade action threatens Brazilian AIDS programme

Brazil may flout trade laws to keep AIDS drugs free for patients

Roche open to discuss patent rights of AIDS drug with Brazil

Crusading Indian firm takes on might of Glaxo SmithKline: Cipla offers anti-HIV drugs at a fraction of rivals’ prices

Post navigation